Phase ll Study of Pirfenidone in Patients With RAILD (TRAIL1)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ivan O. Rosas, M.D.
Brigham and Women's Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
33 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Brompton
Brisbane, Queensland, Australia
- Royal Prince Alfred Hospital
Camperdown, Sydney, Australia
- Melbourne Alfred Hospital
Melbourne, Victoria, Australia
- the Prince Charles Hospital
Camperdown, Australia
- University of Calgary Cummings School of Medicine
Calgary, Alberta, Canada
- St. Paul'S Hospital - Providence Health Care
Vancouver, British Columbia, Canada
- St. Joseph'S Healthcare
Hamilton, Ontario, Canada
- Toronto General Hospital
Toronto, Ontario, Canada
- North Bristol Nhs Trust Headquarters, Southmead Hospital
Bristol, United Kingdom
- Papworth Hospital Nhs Foundation Trust
Cambridge, United Kingdom
- Royal Devon and Exeter Nhs Foundation
Exeter, United Kingdom
- Leeds Teaching Hospitals Nhs Trust
Leeds, United Kingdom
- University Hospitals of Leicester Nhs Foundation Trust
Leicester, United Kingdom
- Aintree University Hospitals Nhs Foundation Trust
Liverpool, United Kingdom
- Royal Brompton and Harefield Nhs Foundation Trust
London, United Kingdom
- Manchester University Nhs Foundation Trust (south) Wythenshawe Hospita
Manchester, United Kingdom
- Newcastle Upon Tyne Hospitals Nhs Foundation Trust
Newcastle upon Tyne, United Kingdom
- Norfolk and Norwich University Hospitals Nhs Foundation Trust
Norwich, United Kingdom
- Oxford University Hospitals Nhs Foundation Trust
Oxford, United Kingdom
- University Hospital Southampton Nhs Foundation Trust
Southhampton, United Kingdom
- University of Alabama Site at Birmingham
Birmingham, Alabama, United States
- University of California San Francisco
San Francisco, California, United States
- National Jewish Health
Denver, Colorado, United States
- University of Miami
Miami, Florida, United States
- Tulane Medical Center
New Orleans, Louisiana, United States
- John Hopkins Medicine
Baltimore, Maryland, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Weill Cornell Medicine
New York, New York, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- University of Utah Health Care
Salt Lake City, Utah, United States
- University of Washington
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 Apr 2017
- Primary completion
- 7 Apr 2021
- Completion
- 7 Apr 2021
- Last update posted
- 16 Aug 2022
- Registered enrollment
- 123
- Registry id
- NCT02808871
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.